Fuxin Han

3PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 15, 2026
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trial.

|Mar 10, 2026
Five-Year Follow-Up: Tandem CD19/CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non-Hodgkin Lymphoma.

Fuxin Han, Yadi Zhong, Chuan Tong

|Jan 18, 2026
MCT1 Inhibition Remodels the Tumor Immune Microenvironment for Enhanced Cancer Immunotherapy.

Yipeng Zhang, Chun Liu, Fuxin Han

Pageof 1

Frequent Collaborators

3 joint publications

Weidong Han

3 joint publications

Yao Wang

2 joint publications

Zhiqiang Wu

1 joint publications

Yipeng Zhang